跳至主要内容
临床试验/CTRI/2025/03/081775
CTRI/2025/03/081775尚未招募3 期

RANDOMIZED OPEN LABELLED CLINICAL STUDY TO COMPARE THE EFFICACY OF PIPPALI MODAKA AS PATHYA WITH SHANKHA VATI IN THE MANAGEMENT OF AMLAPITTA WITH SPECIAL REFERENCE TO HYPERACIDITY

DR K SANGEETHA PATIL1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Significant decrease in the symptoms of amlapitta

研究概览

简要总结

Amlapitta is a life style related disease prevalent all over the world.

Amlapitta can be corelated with the Hyperacidity, and is one of the most common disease seen in today’s modern era with the prevalence ranging from 7.6 to 30%.

Nowadays there is a drastic change in life style of mankind in all aspects due to modernization and industrialization making Amlapitta (Hyperacidity) an obstinate disorder escalating in its prevalence

The main Nidanas of Amlapiita are Adhyashana, Ajeerna, Virudha Ahara Sevana due to which there is vitiation of Pitta Dosha leading to Agnimandhya which inturn causes Amlapitta.

Ayurveda mainly emphasizes on prevention of disease by following Ahara, Nidra, Brahmacharya, Dinacharya ,Rutucharya etc. Ahara is one among the Trayopasthambha, which mainly concentrates on Pathya Apathya.

Pathya is the one which is wholesome to Mana and do not have adverse effect, which have great influence in modifying the illness

Pippali Modaka is a Pathya mentioned in the context of Amlapitta, which has three ingredients i.e Khanda Sarkara , Haritaki Churna and Pippali Churna which are cost effective and readily available

Hence this study aims to evaluate the efficacy of Pippali Modaka as Pathya in Amlapitta.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Subjects fulfilling the diagnostic criteria of Amlapitta( hyperacidity ) will be randomly selected.
  • Subjects who are willing to sign the consent and participate in the study.

排除标准

  • Subjects with systematic disorder like DM, 2)Subjects diagnosed with gastric ulcer ,duodenal ulcer, gall bladder ,liver disorders.
  • Subjects with hiatus hernia 4) Subjects habituated to intake of drug ,alcohol and tobacco inducing Amlapitta 5) Subjects who had underwent surgical intervention related to gastrointestinal disorders 6) pregnant and lactating mother.

结局指标

主要结局

Significant decrease in the symptoms of amlapitta

时间窗: 1st Assessment – 0th day | 2nd Assessment – 15th day | Follow up – 22nd day

次要结局

  • generation of in depth analyzed data on different aspect of disease and its treatment.(1st Assessment – 0th day)

研究者

发起方
DR K SANGEETHA PATIL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR SAJITHA K

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH , BANGLORE

研究点 (1)

Loading locations...

相似试验